Exelixis, Inc. (EXEL)
41.46
+0.08
(+0.19%)
USD |
NASDAQ |
Dec 16, 13:45
Exelixis Accounts Payable (Quarterly): 25.35M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 5.082M |
| ADMA Biologics, Inc. | 24.02M |
| Aldeyra Therapeutics, Inc. | 0.0134M |
| Merck & Co., Inc. | 4.147B |
| ACADIA Pharmaceuticals, Inc. | 21.75M |